pharma · Hepatocellular Carcinoma · Acute Lymphoblastic Leukemia
Anhui Provincial Hospital
Anhui Provincial Hospital is a pharma organization headquartered in CN. Primary therapeutic focus areas include Hepatocellular Carcinoma, Acute Lymphoblastic Leukemia. NovaPharmaNews links 2 clinical program(s), 0 drug p
CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Programs
- 2
- Drugs
- 5
- Patents
- 0
Donafenib + Envafolimab
Phase 2 · small molecule · Hepatocellular Carcinoma
Donafenib + Envafolimab for Hepatocellular Carcinoma is a Phase 2 program (small_molecule) at Anhui Provincial Hospital with 1 ClinicalTrials.gov record(s).
Internal code 2023KY433
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Anhui Provincial Hospital
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Hepatocellular Carcinoma
- Status
- active
- Trials
- 1